• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.55% Nasdaq Down 0.96%

    Progenics Pharmaceuticals, Inc. (PGNX)

    -NasdaqGS
    7.39 Down 0.28(3.65%) 3:56PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:7.67
    Open:7.57
    Bid:7.38 x 400
    Ask:7.40 x 300
    1y Target Est:11.25
    Beta:2.127
    Earnings Date:Nov 5 - Nov 9 (Est.)
    Day's Range:7.35 - 7.76
    52wk Range:4.26 - 11.15
    Volume:530,860
    Avg Vol (3m):1,505,280
    Market Cap:514.97M
    P/E (ttm):205.28
    EPS (ttm):0.04
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PGNX

    Comparison

    Symbol% ChgMkt Cap
    PGNXDown 3.65%514.97M
    NKTRUp 1.89%1.47B

    Key Statistics

    Forward P/E (1 yr):27.44
    P/S (ttm):12.35
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.56
    Quarterly EPS Est (Sep-15) :-0.13
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-0.09

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Progenics Pharmaceuticals, Inc. develops medicines for oncology in the United States and internationally. The company’s primary clinical-stage product candidates include prostate specific membrane antigen (PSMA) antibody-drug conjugate, which... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback